The fermenter market has been gaining momentum over the
years due to rising application of fermentation processes in various industries
such as pharmaceuticals, biotechnology, food & beverages among others.
Fermentation is a biochemical process in which microorganisms such as bacteria,
fungi or yeast converts the metabolic energy from a substrate such as sugar
into cellular components such as proteins and convert the biochemical
carbohydrates and fats into ethanol under anaerobic conditions. Fermentation
has several advantages such as improved productivity, conversion of low-cost
raw materials into value-added products, and generation of less waste. As
fermentation continues to play a vital role in producing amino acids,
antibiotics, vaccines, organic acids, and vitamins, the demand for fermenters is
surging across industries.
The Global fermenter market is estimated to be valued at US$ 1.98 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period
2024 To 2031.
Key application areas of fermenters include production of
antibiotics, recombinant proteins, monoclonal antibodies and manufacturing of
beer, wine, spirits, dairy products, feed, and other fermented products.
Key Takeaways
Key players operating in the fermenter market are DSM N. V., GEA GROUP, ALFA
LAVAL AB, BASF SE, JBT CORPORATION, CHR. HANSEN HOLDINGS A/S , Biotree, Uma
Pharmatech Machinery, Amerging Technologies, DIOSNA Dierks Söhne GmbH,
Pierre Guerin SA, OMVE, SYSBIOTECH GmbH, Shree Biocare Solutions Private
Limited, and Borg Scientific. These players are focusing on new product
launches and expansion strategies to increase their global footprint.
The key opportunities in the
Fermenter
Market demand include increasing adoption of single-use fermenters
among small and medium biopharmaceutical companies owing to operational
flexibility and cost advantages. Growing demand for fermented foods and
beverages is also fueling new opportunities.
Globally, Asia Pacific and North America are expected to witness high growth
owing to expansion of pharmaceutical and food manufacturing capacity in
countries such as China, India, Japan and the U.S. Presence of major medical
devices players is further supporting market growth through facility
expansions.
Market Drivers
The major driver for the fermenter market is the rising
production of biopharmaceutical products such as vaccines, monoclonal
antibodies and therapeutic enzymes. Fermentation is a preferred technology that
enables large-scale, economical manufacturing of complex biologics.
Another key driver is the growing consumption of fermented foods and drinks
including yogurt, cheese, bread, beer, wine and spirits across global
populations. Development of newer fermented probiotic products is also fueling
demand.
Market Restraints
High capital and maintenance cost associated with large
scale fermenters is a major challenge, especially for small and medium
enterprises. Significant investments are required for installing effluent treatment
plants which adds to operational costs.
Stringent regulatory guidelines pertaining to manufacturing and safety of
equipment used for fermentation processes also acts as a market restrain.
Obtaining approvals for large projects require extensive documentation and
compliance.
Segment
Analysis
The fermenter market is segmented based on design
configuration, process, mode of operation, microorganism, end product,
application, and region. Within design configuration, the stirred tank
fermenter segment holds maximum share owing to wide usage in food and beverage,
pharmaceutical, and industrial fermentation processes due to advantages such as
easy operation and scaling up. Within process, the aerobic fermentation segment
dominates as it involves the usage of oxygen for breakdown of organic matter
into energy and simple substances such as carbon dioxide and water by
microorganisms. This process is commonly employed commercially to produce goods
such as ethanol, antibiotics, citric acid, and various amino acids.
Global Analysis
On a regional scale, Asia Pacific dominates the global
fermenter market and is expected to grow at the highest CAGR during the
forecast period. This is attributed to rising population, increased disposable income,
growing urbanization, and changing lifestyle in emerging economies such as
China and India. These factors are propelling the demand for fermented foods,
alcoholic beverages, and other fermentation-based products in the region. North
America holds the second largest share of the global fermenter market due to
well-established food and beverage and pharmaceutical industries. Growing
consumption of processed foods and increasing usage of fermentation technology
for producing antibiotics and biochemicals are driving market growth in the
region.
Get More
Insights On- Fermenter
Market
Comments
Post a Comment